Compare OEC & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OEC | ORGO |
|---|---|---|
| Founded | 1862 | 1985 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.6M | 299.8M |
| IPO Year | 2014 | 2016 |
| Metric | OEC | ORGO |
|---|---|---|
| Price | $7.55 | $2.44 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $6.56 | ★ $8.50 |
| AVG Volume (30 Days) | 426.6K | ★ 712.2K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,806,700,000.00 | $564,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.21 | $26.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $4.35 | $2.04 |
| 52 Week High | $11.60 | $7.08 |
| Indicator | OEC | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 50.71 | 49.62 |
| Support Level | $6.66 | $2.24 |
| Resistance Level | $7.78 | $2.64 |
| Average True Range (ATR) | 0.48 | 0.13 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 40.30 | 65.82 |
Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.